Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Roger Williams Medical Center
Roger Williams Medical Center
Academic / Other · 17 registered clinical trials.
Status
Trial
Phase
Started
Withdrawn
Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma
Pancreatic Adenocarcinoma
Phase 1
2019-12-23
Completed
CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas
Liver Metastases
Phase 1
2017-02-01
Completed
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases
Liver Metastases
Phase 1
2015-04-01
Suspended
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Metastatic Cancers
Phase 2
2012-10-01
Completed
CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells
Liver Metastases
Phase 1
2011-06-01
Terminated
Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic
Non Healing Wounds
Phase 1
2010-06-01
Terminated
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid T
Neoplasms, Tumors, Solid Tumors
Phase 1
2009-10-01
Terminated
Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Colorectal Cancer
Phase 1
2008-05-01
Suspended
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Breast Cancer
Phase 1
2008-05-01
Suspended
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Prostate Cancer
Phase 1
2008-04-01
Terminated
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refrac
Lung Cancer
Phase 1
2007-11-01
Withdrawn
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer
Gastric Cancer
Phase 1
2007-07-01
Suspended
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Monitor Adverse Events
Phase 1 / Phase 2
2006-03-01
Completed
Bioengineered Skin and Wound Healing
Leg Ulcers
Phase 1
2000-10-01
Withdrawn
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
Breast Cancer
Phase 1 / Phase 2
2000-01-01
Completed
Gene Therapy in Treating Patients With Cancer
Cancer
Phase 1
1998-04-01
Completed
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
Leukemia, Lymphoma
Phase 1 / Phase 2
1995-07-01